VALN - Wutah dodolan YoY (TTM) Valneva SE

Tandha merek valneva.com (VALN)

The annual sales growth rate (trailing 12 months) visualizes revenue dynamics, with -22.30 representing the current value of the metric. Valneva SE (VALN) growth relies on partnerships with the public sector and pharma behemoths to combat tropical diseases. High margins are supported by European plants and the cold chain, while supply reliability is guaranteed by strict quality control of international logistics.

VALN (Valneva Vaccines) riwayat Wutah dodolan YoY sajrone rolas wulan kepungkur saka 11.02.2024 nganti 16.11.2026

Valneva - rincian analitis lan metrik utama (VALN)

- rega saham lan target rega konsensus:
Ringkesan analitik perusahaan:VALN (Valneva SE)
Produk asil prodhuksi valneva.com

The operational successes of Valneva SE are reflected in the rolling annual sales growth rate, which neutralizes calendar distortions by comparing revenue over the last 12 months with the same period last year. This metric allows investors to identify hidden demand trends for vaccines, separating summer seasonality from the business's fundamental resilience to macroeconomic shocks.